Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

INNOVATE Biopharmaceuticals

Request full access

Clinical stage biotechnology company developing novel medicines for gastroenterological and orphan disorders

Raleigh, United StatesFounded 2012Biotech & Life Sciences

About INNOVATE Biopharmaceuticals

Innovate Biopharmaceuticals is a publicly traded clinical-stage biotechnology company listed on Nasdaq under the ticker INNT. The company is dedicated to developing innovative medicines aimed at treating autoimmune and inflammatory diseases that currently lack effective treatments. Innovate's pipeline includes several promising drug candidates: Larazotide Acetate (INN 202) in Phase 3 for celiac disease (CeD) with Fast Track designation, INN 217 in preclinical stages for nonalcoholic steatohepatitis (NASH), INN 289 in preclinical stages for a subset of Crohn's disease (CD), and INN 108 in Phase 1 for mild to moderate ulcerative colitis (UC) and a gastrointestinal orphan disease in a convenient liquid formulation.

The company primarily serves patients suffering from these chronic conditions, aiming to provide them with more effective and convenient treatment options. Innovate operates in the biopharmaceutical market, focusing on areas with significant unmet medical needs. Its business model revolves around the development and commercialization of its drug candidates. Revenue generation is expected to come from the successful approval and market launch of these drugs, as well as potential partnerships and licensing agreements.

Innovate is led by a management team with extensive experience in drug development and a proven track record of bringing novel therapeutics to market. The company holds global rights to its products, supported by a robust portfolio of over 150 patents.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2016

INNOVATE Biopharmaceuticals in the Raleigh ecosystem

Live from Dealroom

The INNOVATE Biopharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Raleigh HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about INNOVATE Biopharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See INNOVATE Biopharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.